The inauguration of 1Bio at Genome Valley marks a landmark moment in India’s biologics and next-generation therapeutics landscape. Designed to democratise access to high-quality scale-up and bioprocessing infrastructure, 1Bio will enable innovators, startups and research teams to accelerate their journey from discovery to pilot and clinical readiness with far greater speed, predictability and affordability.
As Genome Valley celebrates 25 years, the launch of 1Bio along with the unveiling of its renewed identity and long-term vision reinforces Telangana’s commitment to building a research-driven, innovation-led future for the life sciences sector. The State continues to position Genome Valley as India’s leading cluster for biotechnology, pharma R&D and advanced manufacturing.
A significant highlight of the event was the launch of the Thermo Fisher–partnered Bioprocess Design Centre, which will serve as a catalyst for high-end bioprocessing innovation. This new centre, combined with upcoming ₹200+ crore in infrastructure upgrades, lays a strong foundation for Genome Valley’s next phase of global competitiveness.
The planned enhancements from state-of-the-art facilities and advanced bioprocessing capabilities to improved connectivity and a signature gateway structure, will further strengthen the cluster’s global presence. These efforts ensure that Telangana remains at the forefront of life sciences innovation for decades to come, driving new opportunities in biologics, biosimilars, cell and gene therapy, and vaccine development.
With 1Bio, Telangana is not just investing in infrastructure, it is investing in the future of healthcare, scientific excellence and India’s place in the global biotech revolution.